{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:11:03Z","timestamp":1793725863802,"version":"4.6.1"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jpsychires.2019.08.014","type":"journal-article","created":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T09:24:09Z","timestamp":1567329849000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Pharmacological and psychological interventions for generalized anxiety disorder in adults: A network meta-analysis"],"prefix":"10.1016","volume":"118","author":[{"given":"Ting-Ren","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer-Hwa","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chen","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Chia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2019.08.014_bib2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/gps.4088","article-title":"Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial","volume":"29","author":"Alaka","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.eurpsy.2007.08.001","article-title":"Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: randomized, double-blind placebo-controlled study","volume":"23","author":"Aliyev","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib4","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1176\/appi.ajp.161.9.1642","article-title":"Efficacy of sertraline in a 12-week trial for generalized anxiety disorder","author":"Allgulander","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib5","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib6","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000339371","article-title":"Internet-based psychodynamic versus cognitive behavioral guided self-help for generalized anxiety disorder: a randomized controlled trial","volume":"81","author":"Andersson","year":"2012","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eurpsy.2017.12.004","article-title":"Disability and common mental disorders: results from the world mental health survey initiative Portugal","volume":"49","author":"Antunes","year":"2018","journal-title":"Eur. Psychiatry : J. Assoc. Eur. Psychiatrists"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1017\/bec.2014.5","article-title":"A randomised controlled trial of acceptance and commitment therapy and cognitive-behaviour therapy for generalised anxiety disorder","author":"Avdagic","year":"2014","journal-title":"Behav. Chang."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1192\/bjp.bp.105.012799","article-title":"Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study","author":"Baldwin","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib11","doi-asserted-by":"crossref","first-page":"d1199","DOI":"10.1136\/bmj.d1199","article-title":"Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis","volume":"342","author":"Baldwin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/15622970601110273","article-title":"Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders","volume":"8","author":"Bandelow","year":"2007","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.euroneuro.2012.07.012","article-title":"Vortioxetine (Lu AA21004) in generalized anxiety disorder: results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial","volume":"22","author":"Bidzan","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1017\/S1092852900025827","article-title":"Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders","volume":"11","author":"Black","year":"2006","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1037\/0022-006X.61.4.611","article-title":"Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder","author":"Borkovec","year":"1993","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.4088\/JCP.v67n0603","article-title":"Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study","author":"Brawman-Mintzer","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/jamapsychiatry.2015.1154","article-title":"Telephone-delivered cognitive behavioral therapy and telephone-delivered nondirective supportive therapy for rural older adults with generalized anxiety disorder: a randomized clinical trial","volume":"72","author":"Brenes","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.pscychresns.2015.06.016","article-title":"Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder","author":"Brown","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1080\/14656566.2017.1359257","article-title":"Agomelatine for the treatment of generalized anxiety disorder","volume":"18","author":"Buoli","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/0022-006X.59.1.167","article-title":"Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder","author":"Butler","year":"1991","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib22","first-page":"46","article-title":"A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder","author":"Bystritsky","year":"2008","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib23","series-title":"Current Medical Research and Opinion","first-page":"215","article-title":"Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo","author":"Casacchia","year":"1990"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/da.20882","article-title":"Suicide attempts versus nonsuicidal self-injury among individuals with anxiety disorders in a nationally representative sample","volume":"29","author":"Chartrand","year":"2012","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib25","first-page":"18","article-title":"A comparative study of paroxetine and alprazolam in the treatment of patients with generalized anxiety disorder","author":"Chen","year":"2006","journal-title":"J. heze Med. Coll."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.invent.2014.08.002","article-title":"The effectiveness of an online e-health application compared to attention placebo or Sertraline in the treatment of Generalised Anxiety Disorder","volume":"1","author":"Christensen","year":"2014","journal-title":"Internet Interv."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1469-8986.2007.00644.x","article-title":"The psychophysiology of generalized anxiety disorder: 2. Effects of applied relaxation","author":"Conrad","year":"2008","journal-title":"Psychophysiology"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2010.10.010","article-title":"Antipsychotic drugs and obesity","volume":"17","author":"Correll","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.janxdis.2011.07.007","article-title":"Combined medication and cognitive therapy for generalized anxiety disorder","volume":"25","author":"Crits-Christoph","year":"2011","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cpr.2014.01.002","article-title":"Psychological treatment of generalized anxiety disorder: a meta-analysis","volume":"34","author":"Cuijpers","year":"2014","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/wps.20346","article-title":"How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence","volume":"15","author":"Cuijpers","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brat.2015.12.007","article-title":"Internet-delivered acceptance-based behaviour therapy for generalized anxiety disorder: a randomized controlled trial","volume":"77","author":"Dahlin","year":"2016","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib33","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4088\/JCP.v60n0805","article-title":"Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder","author":"Davidson","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/da.10146","article-title":"Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study","author":"Davidson","year":"2004","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1192\/bjp.bp.115.168203","article-title":"Repetitive transcranial magnetic stimulation for generalised anxiety disorder: a pilot randomised, double-blind, sham-controlled trial","volume":"209","author":"Diefenbach","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pnpbp.2017.05.018","article-title":"Repetitive transcranial magnetic stimulation of the right dorsal lateral prefrontal cortex in the treatment of generalized anxiety disorder: a randomized, double-blind sham controlled clinical trial","volume":"78","author":"Dilkov","year":"2017","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF03259411","article-title":"Buspirone vs alprazolam: a double-blind comparative study of their efficacy, adverse effects and withdrawal symptoms","author":"Dimitriou","year":"1992","journal-title":"Drug Invest."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1037\/0022-006X.71.4.821","article-title":"Group cognitive-behavioral therapy for generalized anxiety disorder: treatment outcome and long-term follow-up","author":"Dugas","year":"2003","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.beth.2008.12.004","article-title":"A randomized clinical trial of cognitive-behavioral therapy and applied relaxation for adults with generalized anxiety disorder","volume":"41","author":"Dugas","year":"2010","journal-title":"Behav. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib144","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.4088\/JCP.15m09885","article-title":"Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial","volume":"77","author":"Durgam","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1192\/bjp.165.3.315","article-title":"Cognitive therapy, analytic psychotherapy and anxiety management training for generalised anxiety disorder","author":"Durham","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib42","first-page":"574","article-title":"Cardiovascular safety in depressed patients: focus on venlafaxine","volume":"56","author":"Feighner","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.jcp.0000084032.22282.ff","article-title":"A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder","author":"Feltner","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40303-015-0011-7","article-title":"A systematic review of agomelatine-induced liver injury","volume":"3","author":"Freiesleben","year":"2015","journal-title":"J. Mol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2165\/00023210-199707010-00007","article-title":"Buspirone: an updated review of its clinical pharmacology and therapeutic applications","volume":"7","author":"Fulton","year":"1997","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/acps.12275","article-title":"Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis","volume":"130","author":"Furukawa","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib47","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00213-017-4642-5","article-title":"A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use","volume":"234","author":"Gao","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/da.22365","article-title":"A double-blind, randomized, placebo-controlled, fixed-dose phase iii study of vilazodone in patients with generalized anxiety disorder","volume":"32","author":"Gommoll","year":"2015","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/YIC.0000000000000096","article-title":"Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study","volume":"30","author":"Gommoll","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/eurheartj\/ehq438","article-title":"Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey","volume":"32","author":"Hamer","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/YIC.0b013e32807fb1b2","article-title":"Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial","volume":"22","author":"Hartford","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1037\/a0032871","article-title":"A randomized clinical trial comparing an acceptance-based behavior therapy to applied relaxation for generalized anxiety disorder","volume":"81","author":"Hayes-Skelton","year":"2013","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brat.2011.12.005","article-title":"Randomized controlled trial on the effectiveness of metacognitive therapy and intolerance-of-uncertainty therapy for generalized anxiety disorder","author":"Heiden","year":"2012","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib55","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12888-016-0946-y","article-title":"Long-term disability in anxiety disorders","volume":"16","author":"Hendriks","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/da.20257","article-title":"Human and economic burden of generalized anxiety disorder","volume":"25","author":"Hoffman","year":"2008","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib58","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4088\/JCP.12m08083","article-title":"Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity","volume":"74","author":"Hoge","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib59","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00702-003-0019-5","article-title":"Specific modulation of sigma binding sites by the anxiolytic drug opipramol","volume":"110","author":"Holoubek","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000201936","article-title":"Worry exposure versus applied relaxation in the treatment of generalized anxiety disorder","volume":"78","author":"Hoyer","year":"2009","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib61","first-page":"332","article-title":"A comparison study of sertraline, venlafaxine and alprazolam in treatment of generalized anxiety disorder","volume":"376","author":"Huang","year":"2006","journal-title":"Chin. J. Behav. Med. Sci."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib62","first-page":"528","article-title":"Randomized, double blind controlled trial of trazodone versus alprazolam in the treatment of generalized anxiety disorder","author":"Ji","year":"2004","journal-title":"Chin. J. Evidence-Based Med."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib63","first-page":"295","article-title":"Randomized controlled trial of mono-therapy quetiapine versus mono-therapy paroxetine in the treatment of generalized anxiety disorder","volume":"22","author":"Jiang","year":"2010","journal-title":"Shanghai Arch. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib64","first-page":"917","article-title":"The association between anxiety disorders and suicidal behaviors: a systematic review and meta-analysis","volume":"30","author":"Kanwar","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/YIC.0b013e32831d7980","article-title":"Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial","volume":"24","author":"Kasper","year":"2009","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib66","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S1461145713001557","article-title":"Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder","volume":"17","author":"Kasper","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cpr.2014.03.004","article-title":"A meta-analytic review of psychodynamic therapies for anxiety disorders","volume":"34","author":"Keefe","year":"2014","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.publhealth.29.020907.090847","article-title":"The descriptive epidemiology of commonly occurring mental disorders in the United States","volume":"29","author":"Kessler","year":"2008","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib69","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1037\/0022-006X.68.6.957","article-title":"Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder: evaluation in a controlled clinical trial","author":"Ladouceur","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2016.08.017","article-title":"Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies","volume":"118","author":"Laporte","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib71","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1176\/appi.ajp.2009.09030441","article-title":"Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial","volume":"166","author":"Leichsenring","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib72","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/jama.2008.977","article-title":"Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial","volume":"301","author":"Lenze","year":"2009","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib73","first-page":"87","article-title":"A comparison study of citalopram versus alprazolam in the treatment of generalized anxiety disorder","author":"Li","year":"2004","journal-title":"Shandong Arch. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib74","first-page":"4176","article-title":"Tandospirone for treatment of generalized anxiety: a randomized, double blind and controlled study on the curative effect and reliability","author":"Li","year":"2004","journal-title":"Chin. J. Clin. Rehabil."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib75","first-page":"145","article-title":"A comparison study of sertraline versus alprazolam in the treatment of generalized anxiety disorder","author":"Li","year":"2005","journal-title":"Shandong Arch. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib76","first-page":"252","article-title":"A comparative study of paroxetine and clonazepam in the treatment of patients with generalized anxiety disorder","author":"Li","year":"2005","journal-title":"Shandong Arch. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib77","first-page":"8","article-title":"A randomized, placebo-controlled pilot study of quetiapine-XR monotherapy or adjunctive therapy to antidepressant in acute major depressive disorder with current generalized anxiety disorder","volume":"46","author":"Li","year":"2016","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib78","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.euroneuro.2005.04.010","article-title":"The epidemiology of generalized anxiety disorder in Europe","volume":"15","author":"Lieb","year":"2005","journal-title":"Eur. Neuropsychopharmacol. : J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000082025","article-title":"Efficacy of cognitive behaviour therapy in generalized anxiety disorders. Results of a controlled clinical trial (Berlin CBT-GAD Study)","author":"Linden","year":"2005","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib80","first-page":"495","article-title":"A comparative study between mirtazapine and buspirone in the treatment of generalized anxiety disorder","author":"Liu","year":"2005","journal-title":"Med. J. Chin. Health People"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/ijcp.12328","article-title":"A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder","volume":"68","author":"Mahableshwarkar","year":"2014","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib82","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/hup.2371","article-title":"A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder","volume":"29","author":"Mahableshwarkar","year":"2014","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib83","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S2215-0366(14)70329-3","article-title":"Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis","volume":"1","author":"Mayo-Wilson","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib84","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0005-7967(90)90135-6","article-title":"Development and validation of the Penn state worry Questionnaire","volume":"28","author":"Meyer","year":"1990","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib85","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1440-1819.2009.02055.x","article-title":"Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder","volume":"64","author":"Mokhber","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib86","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004714-200102000-00011","article-title":"Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group","volume":"21","author":"M\u00f6ller","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib87","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4088\/JCP.v67n0511","article-title":"Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine","author":"Montgomery","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib88","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1192\/bjp.bp.107.037788","article-title":"Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder","volume":"193","author":"Montgomery","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib89","series-title":"Generalised Anxiety Disorder and Panic Disorder (With or without Agoraphobia) in Adults: Management in Primary, Secondary and Community Care","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib90","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1017\/S0033291708003401","article-title":"Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial","author":"Nicolini","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib91","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00004850-200411000-00003","article-title":"Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study","author":"Nimatoudis","year":"2004","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib92","first-page":"853","article-title":"Comparison of efficacy of mirtazapine and fluoxetine in treatment of depression with generalized anxiety disorder","author":"Niu","year":"2004","journal-title":"Chin. J. N. Drugs Clin. Remedies"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib93","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0005-7967(99)00095-9","article-title":"Applied relaxation vs. cognitive therapy in the treatment of generalized anxiety disorder","author":"Ost","year":"2000","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib94","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jpsychires.2015.02.017","article-title":"Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysis","volume":"64","author":"Pae","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib95","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/16506073.2011.576699","article-title":"Guided Internet-delivered cognitive behavior therapy for generalized anxiety disorder: a randomized controlled trial","volume":"40","author":"Paxling","year":"2011","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib96","first-page":"169","article-title":"A controlled study of paroxetine and flunipam in the treatment of generalized anxiety disorder","author":"Peng","year":"2006","journal-title":"J. Clin. Psychosom. Dis."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.jcp.0000155820.74832.b0","article-title":"Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing","author":"Pohl","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib98","first-page":"502","article-title":"Comparative clinical evaluation of buspirone and diazepam in generalized anxiety disorders","author":"Ramchandran","year":"1990","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib99","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1517\/14656566.2015.1059424","article-title":"Pharmacological treatment for generalized anxiety disorder in adults: an update","volume":"16","author":"Reinhold","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2011.11.014","article-title":"Humanistic and economic burden of generalized anxiety disorder in North America and Europe","volume":"140","author":"Revicki","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.invent.2016.10.003","article-title":"Effectiveness of an internet-delivered intervention for generalized anxiety disorder in routine care: a randomised controlled trial in a student population","volume":"6","author":"Richards","year":"2016","journal-title":"Internet Interv."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib102","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archpsyc.1993.01820230054005","article-title":"Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam","volume":"50","author":"Rickels","year":"1993","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib103","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1176\/appi.ajp.160.4.749","article-title":"Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study","author":"Rickels","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib104","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpsyc.62.9.1022","article-title":"Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam","author":"Rickels","year":"2005","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010942","article-title":"Internet treatment for generalized anxiety disorder: a randomized controlled trial comparing clinician vs. technician assistance","author":"Robinson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib106","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1600-0447.1997.tb09660.x","article-title":"Paroxetine efficacy in the treatment of generalized anxiety disorder","volume":"95","author":"Rocca","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib107","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1037\/a0012720","article-title":"Efficacy of an acceptance-based behavior therapy for generalized anxiety disorder: evaluation in a randomized controlled trial","volume":"76","author":"Roemer","year":"2008","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib108","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/JCP.0000000000000575","article-title":"Selective serotonin reuptake inhibitors and operative bleeding risk: a review of the literature","volume":"36","author":"Roose","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib109","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4088\/JCP.v64n1016","article-title":"Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control","author":"Rosenthal","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/070674378703200505","article-title":"A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder","author":"Ross","year":"1987","journal-title":"Can. J. Psychiatr. Rev. Canad. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib111","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.euroneuro.2012.07.011","article-title":"Vortioxetine (Lu AA21004) 5mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States","volume":"22","author":"Rothschild","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib112","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"Rucker","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib113","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamapsychiatry.2017.0056","article-title":"Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe","volume":"74","author":"Ruscio","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib114","doi-asserted-by":"crossref","first-page":"h4718","DOI":"10.1136\/bmj.h4718","article-title":"How to read a funnel plot in a meta-analysis","volume":"351","author":"Sedgwick","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib115","first-page":"70","article-title":"Clinical study on buspirone hydrochloride treated for generalized anxiety disorder","author":"Shen","year":"1999","journal-title":"J. Chin. Civil Adm. Med."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib116","first-page":"215","article-title":"Venlafaxine compared to alprazolam in the treatment of generalized anxiety disorder","author":"Shi","year":"2004","journal-title":"Shanghai Arch. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib117","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib118","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib119","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0005-7894(96)80044-X","article-title":"Treatment of generalized anxiety in older adults: a preliminary comparison of cognitive-behavioral and supportive approaches","author":"Stanley","year":"1996","journal-title":"Behav. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/0022-006X.71.2.309","article-title":"Cognitive-behavioral treatment of late-life generalized anxiety disorder","author":"Stanley","year":"2003","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib121","first-page":"92","article-title":"Cognitive-behavior therapy for late-life generalized anxiety disorder in primary care: preliminary findings","author":"Stanley","year":"2003","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib122","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2009.458","article-title":"Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care a randomized clinical trial","volume":"301","author":"Stanley","year":"2009","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib123","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMcp1502514","article-title":"CLINICAL PRACTICE. Generalized anxiety disorder","volume":"373","author":"Stein","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib124","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/JCP.0b013e318184ff5b","article-title":"Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study","volume":"28","author":"Stein","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4088\/JCP.13m08433","article-title":"Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study","volume":"75","author":"Stein","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib126","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.euroneuro.2017.02.007","article-title":"Efficacy and safety of agomelatine (10 or 25 mg\/day) in non-depressed out-patients with generalized anxiety disorder: a 12-week, double-blind, placebo-controlled study","volume":"27","author":"Stein","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib127","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1600-0447.2008.01260.x","article-title":"Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety","volume":"118","author":"Taylor","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib128","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4088\/JCP.v59n1002","article-title":"Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients","volume":"59","author":"Thase","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib129","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/00048670903179269","article-title":"Clinician-assisted Internet-based treatment is effective for generalized anxiety disorder: randomized controlled trial","volume":"43","author":"Titov","year":"2009","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib130","first-page":"155","article-title":"A comparative study between venlafaxine and alprazolam in the treatment of generalized anxiety disorder","author":"Wang","year":"2003","journal-title":"J. Clin. Psychol. Med."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib131","first-page":"365","article-title":"A clinical control study of paroxetine and clonazepam in the treatment of generalized anxiety disorder","volume":"359","author":"Wang","year":"2004","journal-title":"Chin. J. Psychol. Health"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib132","first-page":"740","article-title":"A comparative study of paroxetine and lorazepam in the treatment of generalized anxiety disorder","volume":"18","author":"Weizhen","year":"2004","journal-title":"Chin. Ment. Health J."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib133","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brat.2009.11.013","article-title":"A pilot randomized trial of metacognitive therapy vs applied relaxation in the treatment of adults with generalized anxiety disorder","volume":"48","author":"Wells","year":"2010","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib134","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1037\/0022-006X.71.1.31","article-title":"Treatment of generalized anxiety disorder in older adults","author":"Wetherell","year":"2003","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.beth.2010.07.002","article-title":"Acceptance and Commitment Therapy for generalized anxiety disorder in older adults: a preliminary report","author":"Wetherell","year":"2011","journal-title":"Behav. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib136","first-page":"3260","article-title":"Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China","volume":"124","author":"Wu","year":"2011","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib137","first-page":"105","article-title":"The clinical comparison of citalopram with estazolam in the efficacy for generalized anxiety disorder","author":"Yin","year":"2005","journal-title":"J. Jinggangshan Univ."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib138","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jad.2018.02.012","article-title":"Generalized anxiety disorder in urban China: prevalence, awareness, and disease burden","volume":"234","author":"Yu","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib139","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajp.2017.01.016","article-title":"Efficacy and tolerability of vilazodone for the acute treatment of generalized anxiety disorder: a meta-analysis","volume":"26","author":"Zareifopoulos","year":"2017","journal-title":"Asian J. Psychiatr"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib140","first-page":"23","article-title":"Effect of acceptance-based behavior therapy on severity of symptoms, worry and quality of life in women with generalized anxiety disorder","volume":"6","author":"Zargar","year":"2012","journal-title":"Iran. J. Psychiatry Behav. Sci."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib141","first-page":"135","article-title":"Paroxetine versus alprazolam in treatment of generalized anxiety disorder","author":"Zeng","year":"2003","journal-title":"Sichuan Ment. Health"},{"key":"10.1016\/j.jpsychires.2019.08.014_bib142","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.brat.2006.06.005","article-title":"Dyadic predictors of outcome in a cognitive-behavioral program for patients with generalized anxiety disorder in committed relationships: a \"spoonful of sugar\" and a dose of non-hostile criticism may help","author":"Zinbarg","year":"2007","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.014_bib143","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11126-014-9334-2","article-title":"Venlafaxine versus applied relaxation for generalized anxiety disorder: a randomized controlled study on clinical and electrophysiological outcomes","volume":"86","author":"Zullino","year":"2015","journal-title":"Psychiatr. Q."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619305023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619305023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T03:15:29Z","timestamp":1664248529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395619305023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":143,"alternative-id":["S0022395619305023"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.08.014","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological and psychological interventions for generalized anxiety disorder in adults: A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}